Lung Cancer Screening Software Market
According to Intent Market Research, the Lung Cancer Screening Software Market is expected to grow from USD 36.6 billion in 2024-e at a CAGR of 22.9% to touch USD 154.9 billion by 2030. The Lung Cancer Screening Software Market is dominated by key players such as IBM Corporation, Siemens Healthineers, GE Healthcare, Philips Healthcare and Hitachi Ltd.